Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Elza Friedländer"'
Publikováno v:
American Journal of Clinical Pathology, 142, 4, pp. 459-66
American Journal of Clinical Pathology, 142, 459-66
American Journal of Clinical Pathology, 142, 459-66
Contains fulltext : 138318.pdf (Publisher’s version ) (Open Access) OBJECTIVES: IgG4-related disease is a recently recognized condition that can be associated with lymphadenopathy, with several histologic patterns and increased absolute number and
Autor:
Annamária Kakuk, Elza Friedländer, György Vereb, Anita Kása, András Balla, Tamás Balla, Ludwig M. G. Heilmeyer, Pál Gergely
Publikováno v:
Cytometry Part A. :1174-1183
Background: Previous immunohistochemical investigations could not detect PI4K230, an isoform of mammalian phosphatidylinositol 4-kinases (also called type III α), in the nucleus and nucleolus of cells in spite of its predicted nuclear localization s
Autor:
Peter Nagy, Elza Friedländer, Minna Tanner, Anita I. Kapanen, Kermit L. Carraway, Jorma Isola, Thomas M. Jovin
Publikováno v:
Cancer Research. 65:473-482
Overexpression of erbB2 in breast tumors is associated with poor prognosis and is a target of receptor-oriented cancer therapy. Trastuzumab (Herceptin), a monoclonal antibody against a membrane-proximal epitope in the extracellular region of erbB2, s
Autor:
Thomas M. Jovin, Elza Friedländer, János Szöllosi, Donna J. Arndt-Jovin, György Vereb, Péter Nagy
Publikováno v:
Cytometry Part A. :161-171
Background ErbB2 (HER-2), a member of the epidermal growth factor (EGF) receptor family, is a class I transmembrane receptor tyrosine kinase. Although erbB2 has no known physiologic ligand, it can form complexes with other members of the family and u
Autor:
Almos Klekner, György Vereb, Miklós Petrás, Burt G. Feuerstein, Elza Friedländer, Eva Pintye, János Szöllosi, Tamás Lajtos
Publikováno v:
Neuro-oncology, vol 15, iss 8
Neuro-Oncology, 15, 1027-40
Neuro-Oncology, 15, 8, pp. 1027-40
Neuro-Oncology, 15, 1027-40
Neuro-Oncology, 15, 8, pp. 1027-40
Item does not contain fulltext Introduction Treatment of astrocytoma is frequently hampered by radioresistance of the tumor. In addition to overexpression of ErbB1/EGFR, functional crosstalk between receptor tyrosine kinases and cell adhesion molecul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3bf498c4f80c23bec7f66e745dd02fd
https://escholarship.org/uc/item/1s6818bz
https://escholarship.org/uc/item/1s6818bz
Autor:
Gábor Tóth, Duarte Lisboa, Pál Gergely, Péter Bagossi, Annamária Kakuk, Elza Friedländer, György Vereb
Publikováno v:
Experimental cell research. 314(13)
PI4K230, an isoform of phosphatidylinositol 4-kinase, known primarily as a cytoplasmic membrane-bound enzyme, was detected recently also in the nucleolus of several cells. Here we provide mechanistic insight on the targeting function of its putative
Publikováno v:
Immunology letters. 116(2)
The ErbB family is well known for its significance in oncogenesis. As bad prognostic markers, overexpressed or mutated ErbB1 and ErbB2 have an important role in the molecular diagnosis of various cancers, but as membrane proteins, expressed often sel
Autor:
Lajos Trón, Judit Szabó-Péli, Anna Szabó, Elza Friedländer, Gábor Veress, Enikő Németh, Zoltán Krasznai, Teréz Márián, László Balkay
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 30(1)
Aim To establish the effects of Na+/Ca2+ exchanger (NCX) blockers on 2-[18F]fluoro-2-deoxy- d -glucose (18FDG) and 11C-choline accumulation in different cancer cells. Methods The tumor cells were incubated with NCX inhibitors, and the uptakes of 18FD
Autor:
Zoárd Tibor, Krasznai, Elza, Friedländer, András, Nagy, Gábor, Szabó, György, Vereb, Katalin, Goda, Zoltán, Hernádi
Publikováno v:
Anticancer research. 25(2A)
MDR1-associated P-glycoprotein-dependent multidrug resistance is a common cause of chemotherapy failure in patients with advanced ovarian cancer. Here, we describe a clinical method for simultaneously assessing the expression and function of the MDR1
Autor:
Peter, Nagy, Elza, Friedländer, Minna, Tanner, Anita I, Kapanen, Kermit L, Carraway, Jorma, Isola, Thomas M, Jovin
Publikováno v:
Cancer research. 65(2)
Overexpression of erbB2 in breast tumors is associated with poor prognosis and is a target of receptor-oriented cancer therapy. Trastuzumab (Herceptin), a monoclonal antibody against a membrane-proximal epitope in the extracellular region of erbB2, s